Impact of Weight-Loss Drugs on Plus-Size Modelling Industry

The rise of weight-loss drugs such as Ozempic and Wegovy is significantly impacting the fashion industry, raising questions about the future of plus-size modelling.

According to Impact Analytics, a company specializing in artificial intelligence-based planning and forecasting, the widespread usage of GLP-1 drugs, originally prescribed for diabetes, has led to a decrease in the sales of larger clothing sizes. Recent data indicates a 12 percent increase in sales of small-sized clothing and a 10.9 percent decrease for larger sizes.

This trend reflects broader changes within the fashion realm, particularly affecting plus-size models who have historically fought for representation in an industry that has favored narrow beauty standards.

Many plus-size models have voiced their concerns about being overlooked as the popularity of weight-loss therapies grows. Several models report a decline in job bookings from fashion brands they previously collaborated with, thereby igniting a debate about the industry’s trajectory.

While some argue that the shrinking clothing sizes accurately reflect the current customer body types, others believe that the decline in plus-size modelling representation is outpacing the actual changes in consumer sizes. Despite the potential weight loss seen with drugs like Ozempic, the overall weight of the American population suggests that many are still struggling with obesity.

Data from the 2023 fashion season revealed a decrease in the presence of plus-size models compared to previous years. Their inclusion in fashion shows and campaigns represented a significant shift toward inclusivity, fostering a sense of broader representation and relatability.

The economic implications of reducing plus-size visibility are profound. The plus-size market has previously demonstrated its potential to drive sales through diverse representation. Brands like Ganni and Sinéad O’Dwyer have successfully shown that inclusivity can be both a financially viable and ethically responsible approach.

The current trend away from plus-size models could create a disconnect between fashion brands and a substantial consumer base, potentially resulting in a backlash and loss of customer loyalty.